Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies.

Vitale A, Navaglia F, Ramírez Morales R, Frigo AC, Basso D, D'Amico F, Zanus G, Bonsignore P, Farinati F, Burra P, Senzolo M, Grigoletto F, Plebani M, Cillo U.

PLoS One. 2011;6(9):e23093. doi: 10.1371/journal.pone.0023093. Epub 2011 Sep 1.

2.

α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.

Kamiyama T, Takahashi M, Nakanishi K, Yokoo H, Kamachi H, Kobayashi N, Ozaki M, Todo S.

World J Gastroenterol. 2012 Jan 28;18(4):340-8. doi: 10.3748/wjg.v18.i4.340.

3.

AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.

Kamiyama T, Takahashi M, Nakagawa T, Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki M, Matsushita M, Furukawa H, Todo S.

Ann Surg. 2006 Sep;244(3):451-63.

4.

The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.

Gómez-Rodríguez R, Romero-Gutiérrez M, Artaza-Varasa T, González-Frutos C, Ciampi-Dopazo JJ, de-la-Cruz-Pérez G, Sánchez-Ruano JJ.

Rev Esp Enferm Dig. 2012 Jun;104(6):298-304. English, Spanish.

5.

Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma.

Cillo U, Vitale A, Navaglia F, Basso D, Montin U, Bassanello M, D'Amico F, Ciarleglio FA, Brolese A, Zanus G, De Pascale V, Plebani M, D'Amico DF.

World J Gastroenterol. 2005 Nov 28;11(44):6920-5.

6.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
7.

Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?

Zhang Y, Song T, Meng L, Wu X, Ba Y, Li Q.

ANZ J Surg. 2009 Jan-Feb;79(1-2):62-9. doi: 10.1111/j.1445-2197.2008.04801.x.

PMID:
19183381
8.

alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.

Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M.

Hepatology. 2002 Apr;35(4):853-60.

PMID:
11915031
9.

Clinical significance of alpha-fetoprotein mRNA in peripheral blood in liver resection for hepatocellular carcinoma.

Marubashi S, Nagano H, Wada H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M.

Ann Surg Oncol. 2011 Aug;18(8):2200-9. doi: 10.1245/s10434-011-1577-7. Epub 2011 Feb 8.

PMID:
21301972
10.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

PMID:
22672818
11.

Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.

Santambrogio R, Opocher E, Costa M, Barabino M, Zuin M, Bertolini E, De Filippi F, Bruno S.

Ann Surg Oncol. 2012 Feb;19(2):426-34. doi: 10.1245/s10434-011-1845-6. Epub 2011 Jul 6.

PMID:
21732145
12.

Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.

Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y.

Anticancer Res. 2013 Mar;33(3):1013-21.

PMID:
23482775
13.

[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].

Shi M, Zhang Y, Zhong C, Lin XJ, Zhang CQ, Li JQ.

Ai Zheng. 2008 Jan;27(1):83-7. Chinese.

PMID:
18184471
14.

Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.

Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Sugimachi K.

Cancer. 1996 Nov 15;78(10):2094-100.

PMID:
8918402
15.

A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy.

Xia Y, Yan ZL, Xi T, Wang K, Li J, Shi LH, Wu MC, Shen F.

Hepatogastroenterology. 2012 Oct;59(119):2248-54.

PMID:
22366528
16.

Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.

Marubashi S, Dono K, Nagano H, Sugita Y, Asaoka T, Hama N, Miyamoto A, Takeda Y, Umeshita K, Monden M.

Transpl Int. 2007 Jul;20(7):576-82. Epub 2007 Apr 8.

17.

Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.

Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1417-24.

PMID:
19950803
18.
19.

[Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].

Li BD, Zhao QC, Zhu YT, Zhang FQ, Dou KF.

Zhonghua Wai Ke Za Zhi. 2006 Apr 1;44(7):458-62. Chinese.

PMID:
16772080
20.

Supplemental Content

Support Center